|
1
|
Hua Q, Jin M, Mi B, Xu F, Li T, Zhao L,
Liu J and Huang G: LINC01123, a c-Myc-activated long non-coding
RNA, promotes proliferation and aerobic glycolysis of non-small
cell lung cancer through miR-199a-5p/c-Myc axis. J Hematol Oncol.
12:912019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ruiz EJ, Diefenbacher ME, Nelson JK,
Sancho R, Pucci F, Chakraborty A, Moreno P, Annibaldi A, Liccardi
G, Encheva V, et al: LUBAC determines chemotherapy resistance in
squamous cell lung cancer. J Exp Med. 216:450–465. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen J, Liu A, Wang Z, Wang B, Chai X, Lu
W, Cao T, Li R, Wu M, Lu Z, et al: LINC00173.v1 promotes
angiogenesis and progression of lung squamous cell carcinoma by
sponging miR-511-5p to regulate VEGFA expression. Mol Cancer.
19:982020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Deng W, Xu T, Xu Y, Wang Y, Liu X, Zhao Y,
Yang P and Liao Z: Survival patterns for patients with resected n2
non-small cell lung cancer and postoperative radiotherapy: A
prognostic scoring model and heat map approach. J Thorac Oncol.
13:1968–1974. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee SM, Khan I, Upadhyay S, Lewanski C,
Falk S, Skailes G, Marshall E, Woll PJ, Hatton M, Lal R, et al:
First-line erlotinib in patients with advanced non-small-cell lung
cancer unsuitable for chemotherapy (TOPICAL): A double-blind,
placebo-controlled, phase 3 trial. Lancet Oncol. 13:1161–1170.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cho J, Min HY, Lee HJ, Hyun SY, Sim JY,
Noh M, Hwang SJ, Park SH, Boo HJ, Lee HJ, et al: RGS2-mediated
translational control mediates cancer cell dormancy and tumor
relapse. J Clin Invest. 131:e1367792021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Karnthaler-Benbakka C, Groza D, Kryeziu K,
Pichler V, Roller A, Berger W, Heffeter P and Kowol CR:
Tumor-targeting of EGFR inhibitors by hypoxia-mediated activation.
Angew Chem Int Ed Engl. 53:12930–12935. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Phuchareon J, McCormick F, Eisele DW and
Tetsu O: EGFR inhibition evokes innate drug resistance in lung
cancer cells by preventing Akt activity and thus inactivating Ets-1
function. Proc Natl Acad Sci USA. 112:E3855–E3863. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jeong Y, Hellyer JA, Stehr H, Hoang NT,
Niu X, Das M, Padda SK, Ramchandran K, Neal JW, Wakelee H and Diehn
M: Role of KEAP1/NFE2L2 mutations in the chemotherapeutic response
of patients with non-small cell lung cancer. Clin Cancer Res.
26:274–281. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nokihara H, Lu S, Mok TSK, Nakagawa K,
Yamamoto N, Shi YK, Zhang L, Soo RA, Yang JC, Sugawara S, et al:
Randomized controlled trial of S-1 versus docetaxel in patients
with non-small-cell lung cancer previously treated with
platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer).
Ann Oncol. 28:2698–2706. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang W, Gao Y, Li P, Shi Z, Guo T, Li F,
Han X, Feng Y, Zheng C, Wang Z, et al: VGLL4 functions as a new
tumor suppressor in lung cancer by negatively regulating the
YAP-TEAD transcriptional complex. Cell Res. 24:331–343. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Engelen M, Safar AM, Bartter T, Koeman F
and Deutz NEP: High anabolic potential of essential amino acid
mixtures in advanced nonsmall cell lung cancer. Ann Oncol.
26:1960–1966. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gu HF, Mao XY and Du M: Prevention of
breast cancer by dietary polyphenols-role of cancer stem cells.
Crit Rev Food Sci Nutr. 60:810–825. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gunther S, Ruhe C, Derikito MG, Bose G,
Sauer H and Wartenberg M: Polyphenols prevent cell shedding from
mouse mammary cancer spheroids and inhibit cancer cell invasion in
confrontation cultures derived from embryonic stem cells. Cancer
Lett. 250:25–35. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thangapazham RL, Singh AK, Sharma A,
Warren J, Gaddipati JP and Maheshwari RK: Green tea polyphenols and
its constituent epigallocatechin gallate inhibits proliferation of
human breast cancer cells in vitro and in vivo. Cancer Lett.
245:232–241. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Adhami VM, Malik A, Zaman N, Sarfaraz S,
Siddiqui IA, Syed DN, Afaq F, Pasha FS, Saleem M and Mukhtar H:
Combined inhibitory effects of green tea polyphenols and selective
cyclooxygenase-2 inhibitors on the growth of human prostate cancer
cells both in vitro and in vivo. Clin Cancer Res. 13:1611–1619.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shanafelt TD, Call TG, Zent CS, LaPlant B,
Bowen DA, Roos M, Secreto CR, Ghosh AK, Kabat BF, Lee MJ, et al:
Phase I trial of daily oral Polyphenon E in patients with
asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J Clin
Oncol. 27:3808–3814. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu F, Zhou L, Jin W, Yang W, Wang Y, Yan
B, Du W, Zhang Q, Zhang L, Guo Y, et al: Anti-proliferative and
apoptosis-inducing effect of theabrownin against non-small cell
lung adenocarcinoma A549 cells. Front Pharmacol. 7:4652016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu J, Xiao X, Yan B, Yuan Q, Dong X, Du Q,
Zhang J, Shan L, Ding Z, Zhou L and Efferth T: Green tea-derived
theabrownin induces cellular senescence and apoptosis of
hepatocellular carcinoma through p53 signaling activation and
bypassed JNK signaling suppression. Cancer Cell Int. 22:392022.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiao X, Guo L, Dai W, Yan B, Zhang J, Yuan
Q, Zhou L, Shan L and Efferth T: Green tea-derived theabrownin
suppresses human non-small cell lung carcinoma in xenograft model
through activation of not only p53 signaling but also MAPK/JNK
signaling pathway. J Ethnopharmacol. 291:1151672022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Almatroodi SA, Almatroudi A, Khan AA,
Alhumaydhi FA, Alsahli MA and Rahmani AH: Potential therapeutic
targets of epigallocatechin gallate (EGCG), the most abundant
catechin in green tea, and its role in the therapy of various types
of cancer. Molecules. 25:31462020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang Y, Pei J, Zheng Y, Miao YJ, Duan BZ
and Huang LF: Gallic acid: A potential anti-cancer agent. Chin J
Integr Med. 28:661–671. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rios-Doria J, Stevens C, Maddage C, Lasky
K and Koblish HK: Characterization of human cancer xenografts in
humanized mice. J Immunother Cancer. 8:e0004162020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hsieh SC, Wu CC, Hsu SL and Yen JH:
Molecular mechanisms of gallic acid-induced growth inhibition,
apoptosis, and necrosis in hypertrophic scar fibroblasts. Life Sci.
179:130–138. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun G, Ding XA, Argaw Y, Guo X and Montell
DJ: Akt1 and dCIZ1 promote cell survival from apoptotic caspase
activation during regeneration and oncogenic overgrowth. Nat
Commun. 11:57262020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marquez-Jurado S, Diaz-Colunga J, das
Neves RP, Martinez-Lorente A, Almazán F, Guantes R and Iborra FJ:
Mitochondrial levels determine variability in cell death by
modulating apoptotic gene expression. Nat Commun. 9:3892018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu X, He Y, Li F, Huang Q, Kato TA, Hall
RP and Li CY: Caspase-3 promotes genetic instability and
carcinogenesis. Mol Cell. 58:284–296. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peron S, Pan-Hammarstrom Q, Imai K, Du L,
Taubenheim N, Sanal O, Marodi L, Bergelin-Besançon A, Benkerrou M,
de Villartay JP, et al: A primary immunodeficiency characterized by
defective immunoglobulin class switch recombination and impaired
DNA repair. J Exp Med. 204:1207–1216. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nick AM, Stone RL, Armaiz-Pena G, Ozpolat
B, Tekedereli I, Graybill WS, Landen CN, Villares G, Vivas-Mejia P,
Bottsford-Miller J, et al: Silencing of p130cas in ovarian
carcinoma: A novel mechanism for tumor cell death. J Natl Cancer
Inst. 103:1596–1612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chaudhuri AR and Nussenzweig A: The
multifaceted roles of PARP1 in DNA repair and chromatin
remodelling. Nat Rev Mol Cell Biol. 18:610–621. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wei H and Yu X: Functions of PARylation in
DNA damage repair pathways. Genomics Proteomics Bioinformatics.
14:131–139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Salvesen GS: Caspase 8: Igniting the death
machine. Structure. 7:R225–R229. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fritsch M, Gunther SD, Schwarzer R, Albert
MC, Schorn F, Werthenbach JP, Schiffmann LM, Stair N, Stocks H,
Seeger JM, et al: Caspase-8 is the molecular switch for apoptosis,
necroptosis and pyroptosis. Nature. 575:683–687. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mita AC, Mita MM, Nawrocki ST and Giles
FJ: Survivin: Key regulator of mitosis and apoptosis and novel
target for cancer therapeutics. Clin Cancer Res. 14:5000–5005.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peng J, Zhu S, Hu L, Ye P, Wang Y, Tian Q,
Mei M, Chen H and Guo X: Wild-type rabies virus induces autophagy
in human and mouse neuroblastoma cell lines. Autophagy.
12:1704–1720. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim KH and Lee MS: Autophagy-a key player
in cellular and body metabolism. Nat Rev Endocrinol. 10:322–337.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hippert MM, O'Toole PS and Thorburn A:
Autophagy in cancer: Good, bad, or both? Cancer Res. 66:9349–9351.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hait WN, Jin S and Yang JM: A matter of
life or death (or both): Understanding autophagy in cancer. Clin
Cancer Res. 12:1961–1965. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hu Z, Zhang J and Zhang Q: Expression
pattern and functions of autophagy-related gene atg5 in zebrafish
organogenesis. Autophagy. 7:1514–1527. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu H, Liu S, Qiu X, Yang X, Bao L, Pu F,
Liu X, Li C, Xuan K, Zhou J, et al: Donor MSCs release apoptotic
bodies to improve myocardial infarction via autophagy regulation in
recipient cells. Autophagy. 16:2140–2155. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kumar D, Shankar S and Srivastava RK:
Rottlerin-induced autophagy leads to the apoptosis in breast cancer
stem cells: Molecular mechanisms. Mol Cancer. 12:1712013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Awan FM, Obaid A, Ikram A and Janjua HA:
Mutation-structure-function relationship based integrated strategy
reveals the potential impact of deleterious missense mutations in
autophagy related proteins on hepatocellular carcinoma (HCC): A
comprehensive informatics approach. Int J Mol Sci. 18:1392017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kim J, Kundu M, Viollet B and Guan KL:
AMPK and mTOR regulate autophagy through direct phosphorylation of
Ulk1. Nat Cell Biol. 13:132–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xu L, Yue Q, Bian F, Sun H, Zhai H and Yao
Y: Melatonin enhances phenolics accumulation partially via ethylene
signaling and resulted in high antioxidant capacity in grape
berries. Front Plant Sci. 8:14262017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Speranza S, Knechtl R, Witlaczil R and
Schonlechner R: Reversed-phase HPLC characterization and
quantification and antioxidant capacity of the phenolic acids and
flavonoids extracted from eight varieties of sorghum grown in
Austria. Front Plant Sci. 12:7691512021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jang YG, Ko EB and Choi KC: Gallic acid, a
phenolic acid, hinders the progression of prostate cancer by
inhibition of histone deacetylase 1 and 2 expression. J Nutr
Biochem. 84:1084442020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bernhaus A, Fritzer-Szekeres M, Grusch M,
Saiko P, Krupitza G, Venkateswarlu S, Trimurtulu G, Jaeger W and
Szekeres T: Digalloylresveratrol, a new phenolic acid derivative
induces apoptosis and cell cycle arrest in human HT-29 colon cancer
cells. Cancer Lett. 274:299–304. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhou L, Wu F, Jin W, Yan B, Chen X, He Y,
Yang W, Du W, Zhang Q, Guo Y, et al: Theabrownin inhibits cell
cycle progression and tumor growth of lung carcinoma through
c-myc-related mechanism. Front Pharmacol. 8:752017. View Article : Google Scholar : PubMed/NCBI
|
